Cite
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia.
MLA
Miglino, Maurizio, et al. “WT1 Overexpression at Diagnosis May Predict Favorable Outcome in Patients with de Novo Non-M3 Acute Myeloid Leukemia.” Leukemia & Lymphoma, vol. 52, no. 10, Oct. 2011, pp. 1961–69. EBSCOhost, https://doi.org/10.3109/10428194.2011.585673.
APA
Miglino, M., Colombo, N., Pica, G., Grasso, R., Clavio, M., Bergamaschi, M., Ballerini, F., Ghiso, A., Ghiggi, C., Mitscheunig, L., Beltrami, G., Cagnetta, A., Vignolo, L., Lucchetti, M. V., Aquino, S., Pierri, I., Sessarego, M., Carella, A. M., & Gobbi, M. (2011). WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. Leukemia & Lymphoma, 52(10), 1961–1969. https://doi.org/10.3109/10428194.2011.585673
Chicago
Miglino, Maurizio, Nicoletta Colombo, Gianmatteo Pica, Raffaella Grasso, Marino Clavio, Micaela Bergamaschi, Filippo Ballerini, et al. 2011. “WT1 Overexpression at Diagnosis May Predict Favorable Outcome in Patients with de Novo Non-M3 Acute Myeloid Leukemia.” Leukemia & Lymphoma 52 (10): 1961–69. doi:10.3109/10428194.2011.585673.